Samsung Medical Center
Oncology treatment in South Korea typically costs from $17,300 to $43,200. Total expenses depend on the cancer stage, chosen therapy protocol, and the length of hospitalization required for recovery. Patients seeking care here can expect 30-50% savings compared to the United States for advanced medical services.
Typical Oncology Costs in South Korea
Most specialized oncology centers are located in Seoul, Incheon, and Daegu. While Seoul hosts the largest university hospitals, clinics in Gyeonggi-do or Incheon may offer more competitive pricing for similar treatment plans. Consult with a specialist to get accurate pricing for your specific diagnosis.
| Republic of Korea | Turkey | Austria | |
| Thyroid resection | from $5,000 | from $3,500 | from $10,000 |
| Stomach cancer surgery | from $18,500 | from $12,000 | from $30,000 |
| Removal of spinal cord tumor | from $20,500 | from $9,650 | from $50,000 |
| Removal of liver cancer | from $11,550 | from $10,800 | from $40,000 |
| Removal of colon cancer | from $15,200 | from $14,400 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncology treatment journey.
Dr. Lee Jihyeon is a breast and thyroid surgeon. He has expertise in benign and malignant breast diseases, oncoplastic breast surgery, and Mammotome biopsy. He also treats thyroid and parathyroid diseases. He practices pulmonary intensive care (critical care medicine).
He earned his M.D. from Yonsei University College of Medicine. He completed an internship and a general surgery residency at Yonsei University Severance Hospital. He also pursued a short-term fellowship at the Cancer Institute Hospital of JFCR in Japan.
His past roles include Chief of Surgery at Incheon Christian Hospital and Attending Surgeon at Cheil General Hospital. He served as Director of the Breast Center and as Chairman and Chief of Surgery at Samsung Cheil Hospital. He was Chairman of Surgery and Vice President of Medical Affairs at Cheil General Hospital. He also served as Clinical Professor of Surgery at Gangnam CHA Hospital, CHA University.
Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.
His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.
Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.
He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.
He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.
Dr. Lee Chunyong is a urologist with a PhD in Medicine from Hanyang University College of Medicine. His clinical focus includes kidney and urinary stones (ESWL), prostate diseases (BPH, prostate cancer, prostatitis), sexual dysfunction, vasectomy, cystitis, urinary incontinence, and voiding dysfunction.
He has served as Director of Hanyang University Hospital. He was Chairman and Chief Professor of the Department of Urology at Hanyang University College of Medicine. He served as President and later Honorary President of the Korean Endourological Society. He was also a Board Member of the Société Internationale d'Urologie.
His international roles include Visiting Fellow at UCLA and Visiting Professor at the University of Tübingen. He was featured twice on EBS “Best Doctors,” covering prostatic diseases and kidney and urinary stones.
Written by Anna Leonova
Written by Kateryna Zamkovska
Written by Anna Shchur
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Radiation therapy in South Korea is safe due to high-precision technologies and rigorous international quality standards. Facilities like Severance Hospital hold Joint Commission International (JCI) accreditation to ensure patient safety. Advanced methods like Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT) target tumors with millimeter accuracy.
Bookimed Expert Insight: Data shows that the safest outcomes often come from hospitals with dedicated Cancer Centers, like Samsung Medical Center. These centers handle over 2,000,000 patients annually. This high volume allows doctors to specialize in rare sub-types. It also ensures the technical team has unmatched experience with complex radiation equipment.
Patient Consensus: Patients note that the high-tech equipment makes procedures easier to tolerate than expected. While language can be a concern, professional medical translators are available to explain every step of the treatment plan.
Biopsy results in South Korean oncology centers typically return within 3 to 7 days. Full molecular-pathology reports generally require 7 to 14 days for completion. These rapid timelines allow most patients to begin targeted treatment or immunotherapy within 1 to 3 weeks of their initial diagnostic procedure.
Bookimed Expert Insight: High-volume centers like Samsung Medical Center or Severance Hospital process millions of patients annually. This massive scale creates a factory-like efficiency in their pathology labs that smaller clinics cannot match. For international patients, this means diagnostic wait times are often 50% shorter than in Western countries, directly accelerating the start of specialized chemotherapy or robotic surgery.
Patient Consensus: Patients often note that labs in Seoul process tests much faster than they experienced back home. It is helpful to bring digital copies of previous slides to avoid repeating basic biopsies and save several days during the initial workup.
Major South Korean cancer centers hold Joint Commission International (JCI) accreditation and KOIHA certification. Samsung Medical Center, Severance Hospital, and Asan Medical Center lead this group. These facilities maintain high safety standards. They integrate robotic surgery and proton beam therapy for complex oncology cases.
Bookimed Expert Insight: Patient volume is a reliable quality signal in Seoul. Clinics like Severance and Samsung handle over 2 million patients yearly. Our data shows these high volumes allow hospitals to invest in rare tech like Novalis and Da Vinci systems. This infrastructure often results in more precise surgical outcomes for international patients.
Patient Consensus: Patients emphasize the value of having English-speaking translators present during every test. They note that while larger hospitals are very busy, the professional staff and advanced equipment provide significant reassurance during treatment.
Major oncologic surgery in the Republic of Korea typically requires a hospital stay of 7 days for procedures like robotic prostatectomy or nephrectomy. Some uncomplicated cases allow discharge within 3–5 days. High-volume centers like Severance Hospital and Asan Medical Center prioritize efficient recovery through minimally invasive techniques.
Bookimed Expert Insight: Data from leading Seoul hospitals shows a high concentration of specialized robotic systems, with Severance Hospital alone serving 1.6 million outpatients annually. This massive volume allows Korean surgeons to refine rapid-recovery protocols. Patients should note that while clinical care is world-class, basic personal tasks often require a family member or a hired caregiver, as nursing focuses strictly on medical needs.
Patient Consensus: Patients note that the speed of discharge can feel surprising, so it is vital to book a nearby hotel for post-operative recovery. While international departments are helpful, day-to-day communication with ward nurses is easier if you use a translation app for basic requests.
Non-Korean patients can access clinical trials and advanced immunotherapy in the Republic of Korea. Major academic centers like Severance Hospital and Samsung Medical Center actively recruit international participants for Phase 2 and Phase 3 trials. Access requires matching specific medical criteria and often involves self-funding for experimental protocols.
Bookimed Expert Insight: Data shows that large digital hospitals like Seoul National University Bundang Hospital (SNUBH) use advanced EHR systems to match patients to trials faster. While some trials are free, international patients often enter through paid 'compassionate use' programs. These programs offer faster access to experimental treatments like TIL therapy compared to Western waitlists.
Patient Consensus: Patients note that hiring bilingual assistance is vital for passing medical screenings. Many emphasize that while trials are available, you should prepare for self-pay and request specific visa support letters from the hospital.
Oncology centers in the Republic of Korea provide systematic side-effect monitoring through dedicated mobile applications and 24/7 hotlines. Patients receive comprehensive take-home medication kits. These include antiemetics and painkillers. Specialist nurses often conduct follow-up calls during the first week to track symptoms like nausea or fatigue.
Bookimed Expert Insight: Data from major Seoul centers like Samsung Medical Center shows a trend toward integrated digital health. These 'smart' hospitals use the BESTcare system to sync your home monitoring data directly with hospital electronic records. This prevents medical errors and allows doctors to adjust your take-home prescriptions in real-time based on reported symptoms.
Patient Consensus: Patients note it is important to clarify which medications are for daily use versus 'as needed' items. Many appreciate the dedicated translators who explain complex dosage schedules before they leave the clinic.
Medical tourists in Republic of Korea usually receive a C-3-10 or G-1-10 visa for up to 90 days. Extensions for oncology treatments can reach 6 months with hospital documentation. Caregivers must prove immediate family ties. They often receive shorter 90-day stays requiring rotation or renewal.
Bookimed Expert Insight: While patients often get 6-month leeway for cancer care, caregivers face stricter 90-day limits. Large centers like Severance Hospital or Samsung Medical Center provide the necessary invitation letters, but they cannot guarantee caregiver visa extensions. We recommend planning a rotation of family members for treatments exceeding 3 months to avoid logistical gaps.
Patient Consensus: Patients note that while the medical visa process is smooth, caregivers often struggle with shorter stay limits. One patient mentioned that having a translator from the international department helps navigate these immigration visits without stress.
The Republic of Korea reports a 73.7% overall 5-year relative cancer survival rate. This frequently outperforms other high-income nations. These outcomes are driven by mandatory national screening and high hospital volumes. Centres like Severance Hospital lead in robotic and targeted therapies.
Bookimed Expert Insight: Data suggests Korea’s survival advantage is linked to hospital volume and infrastructure. High-capacity centres like Severance Hospital and Samsung Medical Center treat over 2,000,000 patients annually. This massive scale allows doctors to specialise intensely. For example, Dr Paik Nam-sun at Ewha Womans University Medical Center is recognised globally for pioneering breast-conserving techniques. Large centres also use digital systems like BESTcare to reduce errors and start treatment faster.
Patient Consensus: Patients in the Republic of Korea find the medical staff attentive and the diagnostic equipment excellent. They note that fast access to specialists provides a positive outlook during treatment. Clear multidisciplinary plans also improve their experience.
South Korea routinely uses heavy ion therapy, proton beam therapy, and da Vinci robotic systems for cancer care. Major centres like Severance Hospital and Samsung Medical Center integrate these with AI-driven diagnostics. Multidisciplinary teams use precision genetic profiling to tailor immunotherapy and targeted drug regimens.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and performs 45,000+ operations. This massive volume allows their doctors to maintain rare proficiency in robotic and particle therapies. For Australian patients, this level of clinical experience often exceeds what is available at smaller local units.
Patient Consensus: Patients in the Republic of Korea report that diagnostics like PET/CT and MRI are completed remarkably fast. They feel reassured by the professional translators and the hospital environments that offer hope during treatment.
South Korean specialists frequently treat stomach, thyroid, lung, colorectal, breast, and liver cancers. These centres maintain exceptional success rates. They report a 77% survival rate for gastric cancer and nearly 100% for thyroid cases. High volumes at facilities like Samsung Medical Center drive clinical expertise in robotic and minimally invasive surgeries.
Bookimed Expert Insight: Data suggests Korea is the global benchmark for gastric cancer. This is because specialists there handle unparalleled case volumes. For example, Samsung Medical Center treats over 2,000,000 patients annually. This throughput allows doctors like Prof. Dr Paik Nam-sun to develop proprietary surgical methods. These techniques specifically reduce post-operative complications like reflux disease.
Patient Consensus: Patients in South Korea appreciate the professional translators and streamlined diagnostics. They note that multiple tests often begin the day they arrive. Many highlight the impressive equipment and the comfort of multidisciplinary care for breast or gastric cancers.
Oncology centres in the Republic of Korea require original diagnostic images in DICOM format on a CD or USB. Patients must also provide official pathology reports in English or Korean. Doctors often require physical tissue slides or paraffin blocks for local re-testing to confirm staging.
Bookimed Expert Insight: Top Seoul centres like Seoul National University Bundang Hospital use the BESTcare digital system. This allows staff to upload external CD files into local systems instantly. Patients should arrive 15 minutes early to allow this digital integration. This avoids delays during the specialist consultation.
Patient Consensus: Patients note that bringing duplicate sets of original DICOM files and pathology blocks is essential. Korean doctors often perform a thorough third opinion. They use original files rather than just summaries for precise treatment planning.
Traditional integrated therapies are widely available in the Republic of Korea. A dual medical system allows modern oncology and Traditional Korean Medicine (TKM) to coexist legally. Major university hospitals combine chemotherapy with acupuncture, herbal medicine, and moxibustion to manage side effects.
Bookimed Expert Insight: Many Australians focus on Seoul. However, Incheon-based centres like Na-Eun Hospital and Gachon University Gil Medical Center handle 20,000 to 38,000 patients annually. These facilities often offer faster access to multidisciplinary consultations. Speed is critical when coordinating Western treatments with traditional supportive therapies. This helps to confirm they do not interfere with chemotherapy cycles.
Patient Consensus: Patients in the Republic of Korea find the transition between diagnostic tests and traditional support seamless. This is due to professional interpreters and efficient hospital transfers. They note that doctors provide a positive outlook using integrated care plans.
Caregivers in Republic of Korea oncology wards are known as guardians. They must follow strict rules based on the ward type. Standard wards require one adult guardian present 24/7 to help with daily living. Comprehensive nursing wards prohibit overnight family stays. In these wards, hospital staff handle all hygiene and mobility tasks.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to track patient needs. Patients in 5-bed rooms often report high satisfaction when using these integrated nursing services. These wards remove the need for family to provide physical labour. However, they require formal consent to follow staff-led care protocols.
Patient Consensus: Patients find the hospital environment professional. They note that translators stay nearby during complex diagnostics. While ward conditions vary, constant attention from medical staff provides security during intensive treatment in Republic of Korea.